Abstract
The discipline of risk assessment is currently under pressure from two directions. On the one hand, more and more decisions must be made concerning how resources are to be allocated to reduce human exposure to harmful chemicals, and the assessment of risk from those exposures is often essential in making such decisions. On the other hand, many have emphasized the gaps in scientific knowledge and the reliance on assumptions in risk assessments, and the resulting regulations have been criticized as too lenient by some (Epstein and Swartz 1988; Karstadt 1988; Perera 1988; Bailar et al. 1988) and as too stringent by others (Wilson 1988; Freedman and Zeisel 1988). Risk assessments will always have some component of uncertainty, because we often care about risk at levels well below what is detectable [for example, many environmental regulations strive for a lifetime increased cancer risk of no more than 10“5or 10”6 (Anderson 1988), but the lowest detectable risk in humans is about 10-3, the risk of diethylstilbestrol exposure, which causes a very rare form of tumor (IARC 1987)], and so some extrapolation will always be necessary. Also, because generating information requires the expenditure of money, the ideal risk assessment with perfect information can be approached only for a very limited number of chemicals. Thus, progress in risk assessment will come not only from identifying areas of uncertainty where more research is needed, but also from developing rational procedures for making decisions in the presence of uncertainty.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ames BN, Durston WE, Yamasaki E, Lee FD (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Nat Acad Sci USA 70: 2281–2285
Ames BN, Magaw R, Gold LS (1987) Ranking possible carcinogenic hazards. Science 236: 271– 280
Anderson EL (1988) The risk analysis process. In: Travis CC (ed) Carcinogen risk assessment. Plenum, New York, pp 3–17
Ashby J (1988) Computer assisted short-term test battery design: some questions. Environ Mol Mutagen 11: 443–448
Ashby J, Tennant RW (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutation Res 204: 17–115
Bailar JC III, Crouch EAC, Shaikh R, Spiegalman D (1988) One-hit models of carcinogenesis: conservative or not? Risk Anal 8: 485–497
Brockman HE, DeMarini DM (1988) Utility of shorts-term tests for genetic toxicity in the aftermath of the NTP’s analysis of 73 chemicals. Environ Mol Mutagen 11: 421–435
Brusick D, Ashby J, de Serres F, Lohman P, Matsushima T, Matter B, Mendelsohn M, Waters M (1986) Weight-of-evidence scheme for evaluation and interpretation of short-term results. In: Ramel C, Lambert B, Magnusson J (eds) Genetic toxicology of environmental chemicals, Part B: Genetic effects and applied mutagenesis. Alan R Liss, Inc, New York, pp 121–129
Chankong V, Haimes YY, Rosenkranz HS, Pet-Edwards J (1985) The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach. Mutation Res 153: 135–166
Clayson DB (1987) The need for biological risk assessment in reaching decisions about carcinogens. Mutation Res 185: 243–269
Clayson DB (1989) Can a mechanistic rationale be provided for non-genotoxic carcinogens identified in rodent bioassays? Mutation Res (in press)
Clive D (1988) Genetic toxicology: can we design predictive in vivo assays? Mutation Res 205: 313–330
Douglas GR, Blakey DH, Clayson DB (1988) Genotoxicity tests as predictors of carcinogens: an analysis (ICPEMC Working Paper No. 5). Mutation Res 196: 83–93
Dunkel V, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VE (1984) Reproducibility of microbial mutagenicity assays: I. Tests with Salmonella typhimurium und Escherichia coli using a standard protocol. Environ Mutagen 6 (Suppl 2): 1–251
Dunkel V, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF (1985) Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ Mutagen 7 (Suppl 5): 1–248
Ennever FK, Rosenkranz HS (1988a) Influence of the proportion of carcinogens on the cost effectiveness of short-term tests. Mutation Res 197: 1–13
Ennever FK, Rosenkranz HS (1988b) Indirect estimates of the sensitivity and specificity of the Salmonella assay. Environ Mol Mutagen 11 (Suppl 11 ): 32 (Abstr)
Ennever FK, Noonan TJ, Rosenkranz HS (1987) The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and noncarcinogenicity to humans. Mutagenesis 2: 73–78
Epstein SS, Swartz JB (1988) Carcinogenic risk estimation. Science 240: 1043–1045
Flamm WG, Scheuplein RJ (1988) Use of short-term test data in risk analysis of chemical carcinogens. In: Travis CC (ed) Carcinogen risk assessment. Plenum, New York, pp 37–48
Fleiss JL (1981) Statistical methods for rates and proportions, J. Wiley Sons, New York, 2nd Edn
Freedman DA, Zeisel H (1988) From mouse-to-man: the quantitative assessment of cancer risks. Statist Sci 3: 3–28, 45–56
Galloway SM, Bloom AD, Resnick M, Margolin BH, Nakamura F, Archer P, Zeiger E (1985) Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: comparison of results for 22 compounds in two laboratories. Environ Mutagen 7: 1–51
Gold LS, Sawyer CB, Magaw R, Backman GM, de Veciana M, LeVinson R, Hooper NK, Havender WR, Bernstein L, Peto R, Rike MC, Ames BN (1984) A carcinogenic potency database of the standardized results of animal bioassays. Environ Health Perspect 58: 9–319
Gold LS, de Veciana M, Backman GM, Magaw R, Lopipero R, Smith M, Blumenthal M, Levinson R, Bernstein L, Ames BN (1986) Chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1982. Environ Health Perspect 67: 161–200
Gold LS, Slone TH, Backman GM, Magaw R, Da Costa M, Lopipero P, Blumenthal M, Ames BN (1987) Second chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. Environ Health Perspect 74: 237–329
Green MHL (1988) Short-term tests and the myth of the non-clastogenic mutagen. Mutagenesis 3: 369–371
Haworth S, Lawlor T, Mortelmans K, Speck W, Zeiger E (1983) Salmonella mutagenicity test results for 250 chemicals. Environ Mutagen 5 (Suppl 1 ): 3–142
Heddle JA (1988) Prediction of chemical carcinogenicity from in vitro genetic toxicity. Mutagenesis 3: 287–291
Howard PC, McCoy EC, Rosenkranz HS (1987) Sequential and differing nitroreductive pathways for mutagenic nitropyrenes in Salmonella typhimurium. Mutagenesis 2: 431–432
IARC (1987) IARC Monographs on the evaluation of carcinogenic risk to humans. Overall evaluations of carcionogenicity: an updating of IARC monographs volumes 1 to 42 (Suppl 7 ). International Agency for Research on Cancer. Lyon, France
ICPEMC (International Commission for Protection against Environmental Mutagens and Carcinogens) (1988) Testing for mutagens and carcinogens; the role of short-term genotoxicity assays. Mutation Res 205: 3–12
Karstadt M (1988) Quantitative risk assessment: qualms and questions. Teratogen Carcinogen Mutagen: 8: 137–152
Kier LD, Brusick DJ, Auletta AE, Von Halle E, Brown MM, Simmon VF, Dunkel V, McCann J, Mortelmans K, Prival M, Rao TK, Ray V (1986) The Salmonella typhimurium/mammalian microsomal assay. Mutation Res 168: 69–240
Lave LB, Omenn GS (1986) Cost-effectiveness of short-term tests for carcinogenicity. Nature 324: 29–34
Lave LB, Ennever FK, Rosenkranz HS, Omenn GS (1988) Information value of the rodent bioassay. Nature 336: 631–633
Matsushima T (1987) Chemical safety evaluation in Japan. 175–178
McCoy EC, Rosenkranz EJ, Mermelstein R, Rosenkranz HS (1983) Mutagenic specificity and the prediction of mechanisms and bioactivation pathways of genotoxicants: the mutagenicity of 5-nitroacenapthene as an example. Mutation Res 111: 61–68
Moore JA (1988) Risk assessment reappraisals: letter to the editor. Science 240: 1125
Mortelmans K, Haworth S, Lawlor T, Speck WT, Tainer B, Zeiger E (1986) Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 8: 1–119
NAS (National Academy of Sciences) (1984) Toxicity testing: strategies to determine needs and priorities. National Academy Press, Washington DC
Perera FP (1984) The genotoxic/epigenetic distinction: relevance to cancer policy. Environ Res 34: 175–191
Perera F (1988) EPA cancer risk assessments: letter to the editor. Science 239: 1227
Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW (1987) Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 237: 1309–1316
Rosenkranz HS, Ennever FK (1988) Quantifying genotoxicity and nongenotoxicity. Mutation Res 205: 59–67
Shelby MD (1988) The genetic toxicity of human carcinogens and its implications. Mutation Res 204: 3–15
Stowers SJ, Maronpot RR, Reynolds SH, Anderson MW (1987) The role of oncogenes in chemical carcinogenesis. Environ Health Perspect 75: 81–86
Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236: 933–941
Wilson JD (1988) Risk assessment reappraisals: letter to the editor. Science 240: 1126
Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W (1987) Salmonella mutagenicity tests: III. Results from 255 chemicals. Environ Mutagen 9 (Suppl 9 ): 1–109
Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K (1988) Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen 11 (Suppl 12 ): 1–157
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ennever, F.K. (1990). The Use of Short-Term Genotoxicity Tests in Risk Assessment. In: Obe, G. (eds) Advances in Mutagenesis Research. Advances in Mutagenesis Research, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74955-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-74955-1_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74957-5
Online ISBN: 978-3-642-74955-1
eBook Packages: Springer Book Archive